Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use
First bioequivalent to ONSIOR ® (robenacoxib) Injection equips veterinarians with new, cost-effective NSAID (nonsteroidal anti-inflammatory) option for controlling postoperative pain and inflammation with certain surgical procedures in dogs and cats.
Read More
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.